Skip to main content
Premium Trial:

Request an Annual Quote

Abbott and Tecan to Develop New Sample Preparation System

NEW YORK, Dec. 5-Abbott Laboratories and Tecan said today that they will jointly develop an automated sample preparation system for use in molecular diagnostics.


The system is designed to improve nucleic acid sample preparation for Abbott's diagnostic assays for hepatitis C and HIV. The new system may also be used for other nucleic acid-based diagnostic tests now under development between Abbott and partner Celera Diagnostics.


Abbott will contribute its magnetic separator system to Tecan's Genesis Freedom automated liquid handling workstation. Tecan will manufacture the instruments and Abbott will distribute them and provide technical support.


Financial details were not disclosed.


The two companies plan to launch the system in the first quarter of 2003.


Tecan is an instrument company specializing in liquid handling and detection systems. It is based in Zurich.


For more information, see the press announcement.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.